GHK-Cu and skin claims: what the evidence supports

A recent social media clip has been circulating, claiming that GHK-Cu (copper peptide) can "reverse" skin aging, erase wrinkles, and restore youthful elasticity. The video, which features before-and-after images and enthusiastic narration, implies that a single course of GHK-Cu can dramatically remodel the skin. While GHK-Cu is a well-studied peptide, the evidence does not support such sweeping claims.

What the research actually shows

GHK-Cu is a naturally occurring copper-binding peptide that has been investigated for its role in wound healing and skin remodeling. In vitro and animal studies suggest that GHK-Cu can stimulate collagen production, promote angiogenesis, and modulate inflammation. Some human studies, primarily using topical formulations, have reported improvements in skin elasticity, firmness, and photodamage. However, these studies are often small, short-term, and may have industry funding. The magnitude of effect is modest, and results are not universal.

Limits of the evidence

Most clinical evidence for GHK-Cu in skin is based on topical application, not injection. The clip's suggestion that GHK-Cu can "reverse" aging is an overstatement. Skin aging is multifactorial, and no single peptide can undo years of UV damage, collagen loss, and genetic factors. Moreover, the concentration, formulation, and delivery method matter greatly. What works in a lab dish may not translate to a human face.

Research-use caveat

For researchers and laboratory professionals, GHK-Cu is a valuable tool for studying cell signaling, wound healing, and tissue regeneration. It is not approved for cosmetic or therapeutic use in humans by regulatory agencies. Any use in humans outside of approved clinical trials is experimental and carries unknown risks. The peptide is supplied for research purposes only, and its effects in living organisms are not fully characterized.

Open the full video fact-check page (transcript, takeaways, embedded clip).